An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Chloroquine-induced maculopathy may progress years after drug cessation and an apparent period of visual stability. Both doctor and patients should be fully aware of the risks of retinal toxicity, including delayed onset and progression. It is therefore crucial that regular monitoring continues in affected patients, long after the initial diagnosis of maculopathy.
Keywords:
Drugs: musculoskeletal and joint diseases; Eye.
Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 2014;132:1453–60. 10.1001/jamaophthalmol.2014.3459
-
DOI
-
PubMed
Marmor MF, Kellner U, Lai TY, Tyy L, et al. . Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology 2016;123:1386–94. 10.1016/j.ophtha.2016.01.058
-
DOI
-
PubMed
Kellner S, Weinitz S, Farmand G, et al. . Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation. Br J Ophthalmol 2014;98:200–6. 10.1136/bjophthalmol-2013-303897
-
DOI
-
PubMed
Shinjo SK, Maia OO, Tizziani VA, et al. . Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? Clin Rheumatol 2007;26:1248–53. 10.1007/s10067-006-0478-9
-
DOI
-
PubMed